Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

118.02
+0.23000.20%
Post-market: 118.020.00000.00%18:25 EDT
Volume:817.87K
Turnover:96.51M
Market Cap:231.23B
PE:18.51
High:118.46
Open:117.24
Low:117.24
Close:117.79
Loading ...

Novartis announces planned $23B investment over five years in U.S.

TIPRANKS
·
11 Apr

Novartis Plans to Spend $23 Billion to Build, Expand 10 US Facilities, Reuters Reports

MT Newswires Live
·
11 Apr

Pharma Stocks Surge After Trump's Tariff Pause -- Market Talk

Dow Jones
·
10 Apr

Pharma Stocks Slide Further After Trump Reiterates Tariff Threats on Drugs -- Update

Dow Jones
·
09 Apr

Pharma Stocks Drop After Trump Threatens Tariffs on Medicines -- WSJ

Dow Jones
·
09 Apr

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

Dow Jones
·
09 Apr

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

Dow Jones
·
09 Apr

Trump teases targeted tariffs on overseas drug manufacturers

Dow Jones
·
09 Apr

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure

Zacks
·
04 Apr

Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year

Benzinga
·
04 Apr

Novartis Gets FDA Accelerated Approval for Vanrafia

MT Newswires Live
·
03 Apr

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

Dow Jones
·
03 Apr

Novartis gets FDA accelerated approval for Vanrafia

TIPRANKS
·
03 Apr

Big Pharma Avoids Worst-Case Tariff Scenario -- WSJ

Dow Jones
·
03 Apr

APLS' Empaveli sNDA for 2 Rare Kidney Diseases Gets FDA Priority Tag

Zacks
·
02 Apr

Novartis AG Falls Monday, Outperforms Market

Dow Jones
·
01 Apr

JNJ's Rybrevant-Lazcluze Combo Outshines AZN's Tagrisso in Lung Cancer

Zacks
·
31 Mar

Alphabet's Isomorphic Labs Unit Raises $600 Million for AI-Based Drug Development

MT Newswires Live
·
31 Mar

Novartis Gets FDA Approval for Expanded Pluvicto Indication

MT Newswires Live
·
29 Mar

FDA approves Novartis radioligand therapy Pluvicto for earlier use in mCRPC

TIPRANKS
·
29 Mar